Bill Title: To direct the Secretary of Health and Human Services to streamline regulatory oversight of human cell and tissue products, and for other purposes.

Spectrum: Bipartisan Bill

Status: (Introduced) 2024-05-06 - Referred to the House Committee on Energy and Commerce. [HB8251 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
No bill text drafts for US Congress HB8251 currently on file.

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress HB8251

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress HB8251 currently on file.

Social Comments on US HB8251